Free Trial
LON:DOCS

Dr. Martens (DOCS) Share Price, News & Analysis

GBX 85.35
-0.45 (-0.52%)
(As of 06/7/2024 ET)
Today's Range
83.10
87.90
50-Day Range
67
97
52-Week Range
62
162
Volume
1.28 million shs
Average Volume
1.83 million shs
Market Capitalization
£821.02 million
P/E Ratio
853.50
Dividend Yield
7.03%
Price Target
N/A
DOCS stock logo

About Dr. Martens Stock (LON:DOCS)

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

DOCS Stock Price History

DOCS Stock News Headlines

Dr. Martens plc (DOCS) To Go Ex-Dividend on August 29th
Dr Martens investors should be kicking themselves
Dr. Martens Stock Plunges on Profit Warning, CEO Exit
See More Headlines
Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Footwear & Accessories
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
2,591
Year Founded
N/A

Profitability

Net Income
£103.20 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£977.50 million
Cash Flow
GBX 5.97 per share
Book Value
GBX 37 per share

Miscellaneous

Free Float
N/A
Market Cap
£821.02 million
Optionable
Not Optionable
Beta
0.01
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Kenneth Wilson (Age 58)
    CEO & Director
    Comp: $773k
  • Mr. Onyeije Ogueri Nwokorie (Age 54)
    Chief Brand Officer
    Comp: $67k
  • Mr. Geert Peeters (Age 58)
    Chief Operating Officer
  • Mr. Ronald Garricks
    Chief Information Officer
  • Ms. Meg Johnson
    Chief Marketing Officer
  • Ms. Emily Clare Reichwald (Age 49)
    Chief People & Sustainability Officer and Company Secretary
  • Mr. Sean O'Neill
    Chief Digital Officer
  • Mr. Derek Chan
    President of APAC
  • Mr. Adam M. Meek
    Chief Product Officer
  • Ms. Jennifer Somer
    President of Americas

DOCS Stock Analysis - Frequently Asked Questions

How have DOCS shares performed in 2024?

Dr. Martens' stock was trading at GBX 88.60 at the beginning of 2024. Since then, DOCS shares have decreased by 3.7% and is now trading at GBX 85.35.
View the best growth stocks for 2024 here
.

How often does Dr. Martens pay dividends? What is the dividend yield for Dr. Martens?

Dr. Martens declared a dividend on Thursday, May 30th. Stockholders of record on Thursday, August 29th will be given a dividend of GBX 0.99 per share on Tuesday, October 1st. This represents a dividend yield of 1.18%. The ex-dividend date is Thursday, August 29th. The official announcement can be viewed at this link.
Read our dividend analysis for DOCS
.

Is Dr. Martens a good dividend stock?

Dr. Martens (LON:DOCS) pays an annual dividend of GBX 6 per share and currently has a dividend yield of 6.78%. DOCS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 6,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for DOCS.

How do I buy shares of Dr. Martens?

Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:DOCS) was last updated on 6/9/2024 by MarketBeat.com Staff

From Our Partners